Stay updated on Daratumumab for AML/High-Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for AML/High-Risk MDS Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link in its main content area.
    Difference
    0.5%
    Check dated 2026-10-03T22:09:06.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    No additions or deletions were provided to evaluate. There is nothing to summarize about changes.
    Difference
    0.2%
    Check dated 2026-09-26T22:03:49.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous content and effectively blocking the display of trial information. The study record is no longer accessible through the page.
    Difference
    18%
    Check dated 2026-09-19T21:54:18.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page footer now shows revision v3.6.6, replacing the previous v3.6.5. This reflects a routine version update to the page rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T21:54:27.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This indicates a small update to the page's version metadata, with no changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:28:44.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Expanded the study record with additional sections and documents, including the study protocol and statistical analysis plan PDF, sponsor/collaborator details, and updated dates and outcome measures. These additions provide deeper context about the trial's design, interventions, and results timeline.
    Difference
    47%
    Check dated 2026-08-01T20:03:35.000Z thumbnail image

Stay in the know with updates to Daratumumab for AML/High-Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.